VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ESNT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ESNTEssent Group Ltd.
$64.83$6.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksESNTFinancials

Essent Group Ltd. (ESNT) Financials

15Y historyFree accessUpdated daily

Underwriting profitability remains robust with a 37.3% combined ratio in 2026Q1, though revenue growth has slowed significantly to 1.7% compared to the 29.2% expansion observed in 2023Q4.

ESNT Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11
Revenue1.29B1.26B1.27B1.13B1.02B1.03B955.15M867.57M719.35M576.51M458.26M353.29M239.47M131.4M48.72M14.39M
Revenue Growth %-0.91%-0.49%12.03%11.07%-0.99%7.68%10.1%20.6%24.78%25.8%29.71%47.53%82.24%169.73%238.59%-
Medical Costs & Claims166.27M149.34M81.22M31.54M-174.7M31.06M301.29M32.99M11.57M27.23M006.31M2.32M00
Medical Cost Ratio %12.92%11.84%6.41%2.79%-17.16%3.02%31.54%3.8%1.61%4.72%0%0%2.63%1.77%0%0%
Gross Profit1.12B1.11B1.19B1.1B1.19B997.45M653.86M834.58M707.78M549.28M458.26M353.29M233.16M129.08M48.72M14.39M
Gross Margin %87.08%88.16%93.59%97.21%117.16%96.98%68.46%96.2%98.39%95.28%100%100%97.37%98.23%100%100%
Gross Profit Growth %--6.27%7.86%-7.84%19.61%52.55%-21.65%17.92%28.86%19.86%29.71%51.52%80.63%164.97%238.59%-
Operating Expenses298.95M289.74M330.44M276.54M204.85M175.14M163.76M175.52M161.08M150.71M146.38M124.89M97.23M71.06M62.59M48.84M
OpEx / Revenue %23.23%22.98%26.08%24.45%20.12%17.03%17.15%20.23%22.39%26.14%31.94%35.35%40.6%54.07%128.48%339.44%
Depreciation & Amortization5.09M5.23M5.78M4.53M3.02M3.38M3.33M3.77M3.4M3.92M4.06M3.22M2.46M2.25M15.16M13.59M
Combined Ratio %36.15%34.82%32.49%27.24%2.96%20.05%48.69%24.03%24%30.87%31.94%35.35%43.24%55.84%128.48%339.44%
Operating Income821.59M821.86M855.49M823M988.19M822.31M490.1M659.06M546.7M398.57M311.88M228.4M135.93M58.03M-13.88M-34.45M
Operating Margin %63.85%65.18%67.51%72.76%97.04%79.95%51.31%75.97%76%69.13%68.06%64.65%56.76%44.16%-28.48%-239.44%
Operating Income Growth %--3.93%3.95%-16.72%20.17%67.79%-25.64%20.55%37.17%27.79%36.55%68.03%134.25%518.18%59.72%-
EBITDA826.68M827.1M861.27M827.52M991.21M825.69M493.42M662.83M550.1M402.49M315.95M231.62M138.39M60.28M1.28M-20.86M
EBITDA Margin %64.24%65.59%67.97%73.16%97.34%80.28%51.66%76.4%76.47%69.81%68.95%65.56%57.79%45.87%2.63%-144.97%
Interest Expense32.7M32.7M35.32M30.14M15.61M8.28M9.07M10.15M10.18M5.18M426K00000
Non-Operating Income-32.7M-32.7M-35.32M-30.14M-15.61M-8.28M-9.07M-10.15M-10.18M-5.18M-426K0001.28M-20.86M
Pretax Income821.59M821.86M855.49M823M988.19M822.31M490.1M659.06M546.7M398.57M311.88M228.4M135.93M58.03M-13.88M-34.45M
Pretax Margin %63.85%65.18%67.51%72.76%97.04%79.95%51.31%75.97%76%69.13%68.06%64.65%56.76%44.16%-28.48%-239.44%
Income Tax135.25M131.89M126.09M126.61M156.83M140.53M77.06M103.35M79.34M18.82M89.28M71.07M47.43M-7.39M-333K-895K
Effective Tax Rate %16.46%16.05%14.74%15.38%15.87%17.09%15.72%15.68%14.51%4.72%28.62%31.12%34.89%-12.73%2.4%2.6%
Net Income686.34M689.97M729.4M696.39M831.35M681.78M413.04M555.71M467.36M379.75M222.61M157.33M88.5M65.41M-13.54M-33.55M
Net Margin %53.34%54.72%57.56%61.57%81.64%66.29%43.24%64.05%64.97%65.87%48.58%44.53%36.96%49.78%-27.8%-233.22%
Net Income Growth %-5.09%-5.41%4.74%-16.23%21.94%65.06%-25.67%18.9%23.07%70.59%41.49%77.78%35.29%583%59.64%-
EPS (Diluted)7.266.906.856.507.726.113.885.664.773.992.411.721.030.70-0.35-0.87
EPS Growth %2.78%0.73%5.38%-15.8%26.35%57.47%-31.45%18.66%19.55%65.56%40.12%66.99%47.14%300%59.77%-
EPS (Basic)-6.976.926.567.756.133.895.684.804.072.451.741.050.90-0.35-0.87
Diluted Shares Outstanding94.57M100.02M106.55M107.13M107.65M111.56M106.38M98.23M97.97M95.21M92.25M91.74M85.6M18.1M38.45M38.45M

Key Metrics

Growth RegimeMixed
ProfitabilityStrong
Balance SheetFortress
Cash FlowRobust
Top Statement Risk

Housing market volume sensitivity

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Premium Growth Faces Cyclical Headwinds

As reported in financial statements, Essent's revenue growth has fluctuated significantly, moving from a 29.2% expansion in 2023Q4 to a 1.7% increase by 2026Q1, reflecting the broader challenges of a high-interest-rate environment suppressing new mortgage originations and limiting the company's ability to expand its insurance-in-force base.

The deceleration in top-line growth suggests that the company is struggling to offset the decline in new insurance written with its existing recurring premium base. Investors should monitor whether the recent pivot into title insurance can provide a meaningful revenue offset or if the core mortgage insurance segment remains overly tethered to volatile housing transaction volumes.

Underwriting Profitability Remains Structurally Resilient

Based on the provided income statement data, Essent maintained a combined ratio of 37.3% in 2026Q1, demonstrating that the company continues to generate substantial underwriting profits despite the inherent volatility in loss ratios, which peaked at 17.9% in 2025Q4 before moderating in the most recent quarter.

The consistently low combined ratio indicates that the company's proprietary EssentEDGE pricing engine is effectively managing credit risk, allowing for significant margin capture. While the loss ratio shows periodic spikes, the overall underwriting performance remains robust, suggesting that the company's risk selection remains disciplined even as the macroeconomic environment shifts.

Reserve Volatility Masks Underlying Performance

According to the historical loss data, the company experienced a notable anomaly in 2024Q2 where the loss ratio dropped to -0.1%, suggesting that significant reserve releases or favorable claim development may have temporarily inflated net income during that specific period compared to more normalized quarters.

The wide variance in quarterly loss ratios warrants further investigation into the company's reserving methodology and the extent to which current earnings are reliant on the release of prior-year provisions. Analysts should be cautious in extrapolating peak earnings periods, as these may be driven by accounting adjustments rather than purely organic underwriting improvements.

Operational Efficiency Supports Capital Strength

As evidenced by the company's low debt-to-equity ratio of 0.09%, Essent maintains a fortress balance sheet that provides significant flexibility, allowing the firm to navigate cyclical downturns without the leverage-related pressures that often constrain its more heavily indebted peers in the mortgage insurance sector.

This capital discipline appears to be a core component of the company's strategy, enabling it to return value to shareholders while maintaining a buffer against potential credit stress. The ability to operate with minimal debt suggests that management is prioritizing long-term solvency over aggressive, debt-fueled expansion, which may justify its premium valuation relative to competitors.

ESNT — Frequently Asked Questions

Quick answers to the most common questions about buying ESNT stock.

What was Essent Group Ltd.'s (ESNT) revenue in 2025?

For fiscal year 2025, Essent Group Ltd. (ESNT) reported total revenue of $1.26B. This represents a 8663.8% increase compared to $14.4M in 2011.

Is Essent Group Ltd. (ESNT) profitable?

Essent Group Ltd. (ESNT) is profitable, generating $690.0M in net income for the fiscal year ending 2025 with a net profit margin of 54.7%.

What is Essent Group Ltd.'s operating profit margin?

Essent Group Ltd. (ESNT) reported an operating income of $821.9M, resulting in an operating profit margin of 65.2%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Essent Group Ltd.'s gross profit and gross margin?

Essent Group Ltd. (ESNT) generated $1.11B in gross profit for the year, representing a gross profit margin of 88.2%. This demonstrates the company's core pricing power and production efficiency.